Urokinase and Tissue Plasminogen Activators and Their Inhibitor PAI-1 in Human Tumors

被引：0
作者：
E. S. Gershtein
N. E. Kushlinskii
机构：
[1] Russian Academy of Medical Sciences,N. N. Blokhin Cancer Research Center
来源：
Bulletin of Experimental Biology and Medicine | 2001年 / 131卷
关键词：
urokinase plasminogen activator; tissue plasminogen activator; breast cancer; ovarian cancer; lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The content of urokinase and tissue plasminogen activators and their inhibitor PAI-1 in tumors and histologically intact tissues from patients with breast, ovarian, and non-small-cell lung cancer was measured by enzyme immunoassay. The content of urokinase plasminogen activator and PAI-1 considerably increased in all malignant tumors, however the correlation between the expression of components of the plasminogen activation system and clinical morphological feature and prognosis of the disease depends on the type of tumor.
引用
收藏
页码：67 / 72
页数：5
相关论文
共 33 条
[1]  
Andreasen P. A.(1990)undefined Mol. Cell. Endocrinol. 68 1-19
[2]  
Georg B.(1996)undefined Semin. Thromb. Hemost. 22 459-478
[3]  
Lund L. R.(1994)undefined Thromb. Hemost. 71 684-691
[4]  
Bell W. R.(1999)undefined J. Surg. Oncol. 71 130-135
[5]  
Damjanovich L.(1998)undefined J. Clin. Oncol. 16 3129-3136
[6]  
Turzo C.(2000)undefined Cancer Res 60 636-643
[7]  
Adany R.(1997)undefined Int. J. Biol. Markers 12 6-14
[8]  
Duffy M. J.(1995)undefined Pathol. Res. Pract. 191 403-409
[9]  
Maguire T. M.(1998)undefined Clin. Exp. Metastases 16 9-20
[10]  
McDermott E. W.(1993)undefined Physiol. Rev. 73 161-195
1234